PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY
Orgo-Life the new way to the future Advertising by AdpathwayIn this informative Q&A session, Dr. Ahmet Baschat, director of the Johns Hopkins Center for Fetal Therapy, answers the most common questions surrounding Congenital Diaphragmatic Hernia (CDH) and walks referring providers through the latest approaches to prenatal evaluation, counseling, and management. Whether you’re a maternal-fetal medicine specialist, OB provider, sonographer, or part of a neonatal care team, this video offers practical insights to support clinical decision-making and improve coordinated care. #prenatalcare #johnshopkins #cdh #fetaltherapy https://www.hopkinsmedicine.org/gynecology-obstetrics/specialty-areas/fetal-therapy/conditions-we-treat/congenital-diaphragmatic-hernia 00:22 What is congenital diaphragmatic hernia (CDH)? 1:55 When should CDH be referred to Johns Hopkins? 2:38 What ultrasound findings suggest CDH? 3:13 What is the CDH workup at Johns Hopkins? 3:40 How is CDH severity classified? 5:10 Who is eligible for FETO at Johns Hopkins? 6:06 What are Johns Hopkins’ outcomes with fetal CDH therapy? 7:26 What are the risks and benefits of fetal surgery for CDH? 8:43 Can prenatal care continue locally after evaluation? 9:34 Is in-house delivery required for CDH cases? 10:19 How does Johns Hopkins support shared care? 11:06 What postnatal CDH services does Johns Hopkins offer? 12:42 What long-term support is available for CDH infants? 13:29 How do I refer a patient?

.jpg)










English (US) ·